Reverse transcriptase in motion: conformational dynamics of enzyme-substrate interactions.
暂无分享,去创建一个
S. Sarafianos | S. L. Le Grice | B. Marchand | Stefan Sarafianos | M. Götte | J. Rausch | Matthias Götte | Bruno Marchand | Stuart F J Le Grice | Jason W Rausch
[1] T. Steitz,et al. Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor. , 1992, Science.
[2] S. Sarafianos,et al. YADD Mutants of Human Immunodeficiency Virus Type 1 and Moloney Murine Leukemia Virus Reverse Transcriptase Are Resistant to Lamivudine Triphosphate (3TCTP) In Vitro , 2001, Journal of Virology.
[3] K. White,et al. Effects of the Translocation Status of Human Immunodeficiency Virus Type 1 Reverse Transcriptase on the Efficiency of Excision of Tenofovir , 2007, Antimicrobial Agents and Chemotherapy.
[4] M. Götte. Effects of nucleotides and nucleotide analogue inhibitors of HIV-1 reverse transcriptase in a ratchet model of polymerase translocation. , 2006, Current pharmaceutical design.
[5] R. Hamatake,et al. Novel Nonnucleoside Inhibitors That Select Nucleoside Inhibitor Resistance Mutations in Human Immunodeficiency Virus Type 1 Reverse Transcriptase , 2006, Antimicrobial Agents and Chemotherapy.
[6] J. Arnold,et al. Nucleic acid polymerases employ a general acid for nucleotidyl transfer , 2008, Nature Structural &Molecular Biology.
[7] R. Schinazi,et al. Delayed Chain Termination Protects the Anti-hepatitis B Virus Drug Entecavir from Excision by HIV-1 Reverse Transcriptase* , 2008, Journal of Biological Chemistry.
[8] R. Bambara,et al. Unique progressive cleavage mechanism of HIV reverse transcriptase RNase H. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[9] R. Bambara,et al. Use of an Oligoribonucleotide Containing the Polypurine Tract Sequence as a Primer by HIV Reverse Transcriptase (*) , 1995, The Journal of Biological Chemistry.
[10] D. Hazuda,et al. HIV-1 Reverse Transcriptase Plus-strand Initiation Exhibits Preferential Sensitivity to Non-nucleoside Reverse Transcriptase Inhibitors in Vitro* , 2007, Journal of Biological Chemistry.
[11] W. Rutvisuttinunt,et al. Stable complexes formed by HIV-1 reverse transcriptase at distinct positions on the primer-template controlled by binding deoxynucleoside triphosphates or foscarnet. , 2007, Journal of molecular biology.
[12] R. S. Goody,et al. Multiparameter single-molecule fluorescence spectroscopy reveals heterogeneity of HIV-1 reverse transcriptase:primer/template complexes , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[13] E. Arnold,et al. An expanded model of replicating human immunodeficiency virus reverse transcriptase. , 1995, Biochemistry.
[14] R. Goody,et al. Refined model for primer/template binding by HIV-1 reverse transcriptase: pre-steady-state kinetic analyses of primer/template binding and nucleotide incorporation events distinguish between different binding modes depending on the nature of the nucleic acid substrate. , 1999, Journal of molecular biology.
[15] P K Hansma,et al. Direct observation of one-dimensional diffusion and transcription by Escherichia coli RNA polymerase. , 1999, Biophysical journal.
[16] G L Verdine,et al. Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance. , 1998, Science.
[17] G. Fuller,et al. Characterization of the IL-6 Responsive Elements in the γ Fibrinogen Gene Promoter (*) , 1995, The Journal of Biological Chemistry.
[18] K. Anderson,et al. Mechanism and fidelity of HIV reverse transcriptase. , 1992, The Journal of biological chemistry.
[19] S. L. Le Grice,et al. Investigating HIV-1 Polypurine Tract Geometry via Targeted Insertion of Abasic Lesions in the (–)-DNA Template and (+)-RNA Primer* , 2005, Journal of Biological Chemistry.
[20] A. D. Clark,et al. Structure of unliganded HIV-1 reverse transcriptase at 2.7 A resolution: implications of conformational changes for polymerization and inhibition mechanisms. , 1996, Structure.
[21] S. Hughes,et al. Polypurine tract adjacent to the U3 region of the Rous sarcoma virus genome provides a cis-acting function , 1982, Journal of virology.
[22] M. Wendeler,et al. HIV-1 reverse transcriptase can simultaneously engage its DNA/RNA substrate at both DNA polymerase and RNase H active sites: implications for RNase H inhibition. , 2009, Journal of molecular biology.
[23] J. DeStefano,et al. Determinants of the RNase H cleavage specificity of human immunodeficiency virus reverse transcriptase. , 1993, Nucleic acids research.
[24] S. Benkovic,et al. Human immunodeficiency virus type 1 reverse transcriptase: spatial and temporal relationship between the polymerase and RNase H activities. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[25] A. D. Clark,et al. Crystal structure of HIV‐1 reverse transcriptase in complex with a polypurine tract RNA:DNA , 2001, The EMBO journal.
[26] S. L. Le Grice,et al. Purine analog substitution of the HIV-1 polypurine tract primer defines regions controlling initiation of plus-strand DNA synthesis , 2006, Nucleic acids research.
[27] J. Mccoy,et al. Human immunodeficiency virus 1 reverse transcriptase. Template binding, processivity, strand displacement synthesis, and template switching. , 1989, The Journal of biological chemistry.
[28] B. Marchand,et al. Site-specific Footprinting Reveals Differences in the Translocation Status of HIV-1 Reverse Transcriptase , 2003, Journal of Biological Chemistry.
[29] J. Champoux,et al. RNA-primed initiation of Moloney murine leukemia virus plus strands by reverse transcriptase in vitro , 1984, Journal of virology.
[30] K. Moelling,et al. Characterization of reverse transcriptase and RNase H from friend-murine leukemia virus. , 1974, Virology.
[31] S. L. Le Grice,et al. Attenuation of DNA replication by HIV-1 reverse transcriptase near the central termination sequence. , 2005, Biochemistry.
[32] V. Pathak,et al. Mutations in Human Immunodeficiency Virus Type 1 RNase H Primer Grip Enhance 3′-Azido-3′-Deoxythymidine Resistance , 2007, Journal of Virology.
[33] J. Mellors,et al. Zidovudine resistance is suppressed by mutations conferring resistance of human immunodeficiency virus type 1 to foscarnet , 1996, Journal of virology.
[34] Elio A. Abbondanzieri,et al. Slide into Action: Dynamic Shuttling of HIV Reverse Transcriptase on Nucleic Acid Substrates , 2008, Science.
[35] R. Bambara,et al. Helix Structure and Ends of RNA/DNA Hybrids Direct the Cleavage Specificity of HIV-1 Reverse Transcriptase RNase H (*) , 1996, The Journal of Biological Chemistry.
[36] Elio A. Abbondanzieri,et al. Dynamic binding orientations direct activity of HIV reverse transcriptase , 2008, Nature.
[37] A. D. Clark,et al. Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[38] B. Marchand,et al. The Pyrophosphate Analogue Foscarnet Traps the Pre-translocational State of HIV-1 Reverse Transcriptase in a Brownian Ratchet Model of Polymerase Translocation* , 2007, Journal of Biological Chemistry.
[39] S. Hughes,et al. The history of N-methanocarbathymidine: the investigation of a conformational concept leads to the discovery of a potent and selective nucleoside antiviral agent. , 2006, Antiviral research.
[40] J. Champoux,et al. Recognition of internal cleavage sites by retroviral RNases H. , 2004, Journal of molecular biology.
[41] D. Barford,et al. Crystal structure of the protein serine/threonine phosphatase 2C at 2.0 A resolution. , 1996, The EMBO journal.
[42] S. L. Le Grice,et al. Mutations M184V and Y115F in HIV-1 Reverse Transcriptase Discriminate against “Nucleotide-competing Reverse Transcriptase Inhibitors”* , 2008, Journal of Biological Chemistry.
[43] S. Zanoli,et al. Non-nucleoside HIV-1 reverse transcriptase inhibitors di-halo-indolyl aryl sulfones achieve tight binding to drug-resistant mutants by targeting the enzyme-substrate complex. , 2009, Antiviral research.
[44] A. Telesnitsky,et al. Footprint analysis of replicating murine leukemia virus reverse transcriptase. , 1995, Science.
[45] P. V. von Hippel,et al. Facilitated Target Location in Biological Systems* , 2022 .
[46] Jennifer L. Knight,et al. HIV-1 reverse transcriptase structure with RNase H inhibitor dihydroxy benzoyl naphthyl hydrazone bound at a novel site. , 2006, ACS chemical biology.
[47] H. Gross,et al. HIV‐1 reverse transcriptase‐associated RNase H cleaves RNA/RNA in arrested complexes: implications for the mechanism by which RNase H discriminates between RNA/RNA and RNA/DNA. , 1995, The EMBO journal.
[48] W. Beard,et al. Kinetic analysis of template.primer interactions with recombinant forms of HIV-1 reverse transcriptase. , 1993, Biochemistry.
[49] D W Rodgers,et al. The structure of unliganded reverse transcriptase from the human immunodeficiency virus type 1. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[50] J. Champoux,et al. Analysis of Plus-strand Primer Selection, Removal, and Reutilization by Retroviral Reverse Transcriptases* , 2000, The Journal of Biological Chemistry.
[51] Marc C Nicklaus,et al. Experimental and structural evidence that herpes 1 kinase and cellular DNA polymerase(s) discriminate on the basis of sugar pucker. , 2004, Journal of the American Chemical Society.
[52] P. Harrigan,et al. Connection Domain Mutations N348I and A360V in HIV-1 Reverse Transcriptase Enhance Resistance to 3′-Azido-3′-deoxythymidine through Both RNase H-dependent and -independent Mechanisms , 2008, Journal of Biological Chemistry.
[53] D. Baltimore. Viral RNA-dependent DNA Polymerase: RNA-dependent DNA Polymerase in Virions of RNA Tumour Viruses , 1970, Nature.
[54] J. Champoux,et al. Plus-strand priming by Moloney murine leukemia virus. The sequence features important for cleavage by RNase H. , 1989, Journal of molecular biology.
[55] S. L. Le Grice,et al. Pre-existing Distortions in Nucleic Acid Structure Aid Polypurine Tract Selection by HIV-1 Reverse Transcriptase* , 2002, The Journal of Biological Chemistry.
[56] M. Götte,et al. Effects of mutations in the connection and RNase H domains of HIV-1 reverse transcriptase on drug susceptibility. , 2008, AIDS reviews.
[57] R E Glass,et al. Visualization of single molecules of RNA polymerase sliding along DNA. , 1993, Science.
[58] J. Champoux,et al. Specific Cleavages by RNase H Facilitate Initiation of Plus-Strand RNA Synthesis by Moloney Murine Leukemia Virus , 2003, Journal of Virology.
[59] A. D. Clark,et al. Structures of HIV‐1 reverse transcriptase with pre‐ and post‐translocation AZTMP‐terminated DNA , 2002, The EMBO journal.
[60] Robert G. Brinson,et al. Structural probing of the HIV-1 polypurine tract RNA:DNA hybrid using classic nucleic acid ligands , 2008, Nucleic acids research.
[61] Thomas A Steitz,et al. The Structural Mechanism of Translocation and Helicase Activity in T7 RNA Polymerase , 2004, Cell.
[62] P. Boyer,et al. Fixed conformation nucleoside analogs effectively inhibit excision-proficient HIV-1 reverse transcriptases. , 2005, Journal of molecular biology.
[63] Antoine M. van Oijen,et al. A base-excision DNA-repair protein finds intrahelical lesion bases by fast sliding in contact with DNA. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[64] Stephen H Hughes,et al. Crystallography and the design of anti-AIDS drugs: conformational flexibility and positional adaptability are important in the design of non-nucleoside HIV-1 reverse transcriptase inhibitors. , 2005, Progress in biophysics and molecular biology.
[65] S. L. Le Grice,et al. Hydrolysis of RNA/DNA hybrids containing nonpolar pyrimidine isosteres defines regions essential for HIV type 1 polypurine tract selection , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[66] Robert G. Brinson,et al. Probing anomalous structural features in polypurine tract-containing RNA-DNA hybrids with neomycin B. , 2009, Biochemistry.
[67] S. Sarafianos,et al. The role of steric hindrance in 3TC resistance of human immunodeficiency virus type-1 reverse transcriptase. , 2000, Journal of molecular biology.
[68] Roger A. Jones,et al. Structures of HIV-1 RT–DNA complexes before and after incorporation of the anti-AIDS drug tenofovir , 2004, Nature Structural &Molecular Biology.
[69] J. Hsieh,et al. Kinetic mechanism of the DNA-dependent DNA polymerase activity of human immunodeficiency virus reverse transcriptase. , 1993, The Journal of biological chemistry.
[70] S. Mizutani,et al. Viral RNA-dependent DNA Polymerase: RNA-dependent DNA Polymerase in Virions of Rous Sarcoma Virus , 1970, Nature.
[71] Wei Yang,et al. Structure of human RNase H1 complexed with an RNA/DNA hybrid: insight into HIV reverse transcription. , 2007, Molecular cell.
[72] S. Sharma,et al. Nucleotide-induced stable complex formation by HIV-1 reverse transcriptase. , 1997, Biochemistry.
[73] J. Elf,et al. Probing Transcription Factor Dynamics at the Single-Molecule Level in a Living Cell , 2007, Science.
[74] H. Gross,et al. Localization of the Active Site of HIV-1 Reverse Transcriptase-associated RNase H Domain on a DNA Template Using Site-specific Generated Hydroxyl Radicals* , 1998, The Journal of Biological Chemistry.
[75] K. Hertogs,et al. Indolopyridones Inhibit Human Immunodeficiency Virus Reverse Transcriptase with a Novel Mechanism of Action , 2006, Journal of Virology.
[76] J. Champoux,et al. RNase H activity: structure, specificity, and function in reverse transcription. , 2008, Virus research.
[77] M. Wainberg,et al. Temporal Coordination between Initiation of HIV (+)-Strand DNA Synthesis and Primer Removal* , 1999, The Journal of Biological Chemistry.
[78] F. Clavel,et al. Long-Term Foscarnet Therapy Remodels Thymidine Analogue Mutations and Alters Resistance to Zidovudine and Lamivudine in HIV-1 , 2006, Antiviral therapy.
[79] S. L. Le Grice,et al. Nuclease footprinting of human immunodeficiency virus reverse transcriptase/tRNA(Lys-3) complexes. , 1993, The Journal of biological chemistry.
[80] A. D. Clark,et al. Structure and functional implications of the polymerase active site region in a complex of HIV-1 RT with a double-stranded DNA template-primer and an antibody Fab fragment at 2.8 A resolution. , 1998, Journal of molecular biology.
[81] R. Sousa,et al. A model for the mechanism of polymerase translocation. , 1997, Journal of molecular biology.
[82] J. Champoux,et al. The sequence features important for plus strand priming by human immunodeficiency virus type 1 reverse transcriptase. , 1993, The Journal of biological chemistry.
[83] J. G. Levin,et al. Sequence and structural determinants required for priming of plus-strand DNA synthesis by the human immunodeficiency virus type 1 polypurine tract , 1996, Journal of virology.
[84] C. Ehresmann,et al. Binding and kinetic properties of HIV‐1 reverse transcriptase markedly differ during initiation and elongation of reverse transcription. , 1996, The EMBO journal.
[85] R. Bambara,et al. Strand Displacement Synthesis in the Central Polypurine Tract Region of HIV-1 Promotes DNA to DNA Strand Transfer Recombination* , 1996, The Journal of Biological Chemistry.
[86] L. Loeb,et al. Synthesis of DNA by human immunodeficiency virus reverse transcriptase is preferentially blocked at template oligo(deoxyadenosine) tracts. , 1990, The Journal of biological chemistry.
[87] J. Champoux,et al. Polypurine Tract Primer Generation and Utilization by Moloney Murine Leukemia Virus Reverse Transcriptase* , 1999, The Journal of Biological Chemistry.
[88] A. D. Clark,et al. Crystal structures of clinically relevant Lys103Asn/Tyr181Cys double mutant HIV-1 reverse transcriptase in complexes with ATP and non-nucleoside inhibitor HBY 097. , 2007, Journal of molecular biology.
[89] J. DeStefano,et al. Polymerization and RNase H activities of the reverse transcriptases from avian myeloblastosis, human immunodeficiency, and Moloney murine leukemia viruses are functionally uncoupled. , 1991, The Journal of biological chemistry.
[90] S. L. Le Grice,et al. Using pyrrolo-deoxycytosine to probe RNA/DNA hybrids containing the human immunodeficiency virus type-1 3' polypurine tract. , 2004, Nucleic acids research.
[91] E. Furfine,et al. Reverse transcriptase.RNase H from the human immunodeficiency virus. Relationship of the DNA polymerase and RNA hydrolysis activities. , 1991, The Journal of biological chemistry.
[92] H. Buc,et al. HIV-1 reverse transcription. A termination step at the center of the genome. , 1994, Journal of molecular biology.
[93] J. Arnold,et al. Two proton transfers in the transition state for nucleotidyl transfer catalyzed by RNA- and DNA-dependent RNA and DNA polymerases , 2007, Proceedings of the National Academy of Sciences.
[94] Robert G. Brinson,et al. High-resolution NMR analysis of the conformations of native and base analog substituted retroviral and LTR-retrotransposon PPT primers. , 2008, Chemistry & biology.
[95] R. Hamatake,et al. In Vitro Inhibition of Hepadnavirus Polymerases by the Triphosphates of BMS-200475 and Lobucavir , 1998, Antimicrobial Agents and Chemotherapy.
[96] S. L. Le Grice,et al. Substituting a Conserved Residue of the Ribonuclease H Domain Alters Substrate Hydrolysis by Retroviral Reverse Transcriptase* , 1997, The Journal of Biological Chemistry.
[97] E. Furfine,et al. Human immunodeficiency virus reverse transcriptase ribonuclease H: specificity of tRNA(Lys3)-primer excision. , 1991, Biochemistry.
[98] J. DeStefano,et al. Quantitative analysis of RNA cleavage during RNA-directed DNA synthesis by human immunodeficiency and avian myeloblastosis virus reverse transcriptases. , 1994, Nucleic acids research.
[99] S. L. Le Grice,et al. 'Binding, bending and bonding': polypurine tract-primed initiation of plus-strand DNA synthesis in human immunodeficiency virus. , 2004, The international journal of biochemistry & cell biology.
[100] T. Steitz. DNA Polymerases: Structural Diversity and Common Mechanisms* , 1999, The Journal of Biological Chemistry.